The manufacturer of DTF claims its product reduces facial wrinkles and wishes to sell it as a pharmaceutical. The Food and Drug Administration (FDA), however, has ordered lengthy and costly experiments to determine whether DTF truly reduces facial wrinkles. The manufacturer, a small cosmetics firm, lacks the resources to carry out the required research and will probably comply with less rigorous line FDA regulations by labeling DTF a cosmetic.
Which of the following can be most reasonably inferred from the statements above?
(A) Cosmetics are among the products not regulated by the FDA.
(B) Only established pharmaceutical firms have the capital required to enter new products in the market.
(C) The makers of DTF thought they would sell greater quantities of their product if it were a pharmaceutical rather than a cosmetic.
(D) The FDA regulates claims made about pharmaceuticals more strictly than claims made about cosmetics.
(E) DTF has very little effect, if any, on facial line wrinkles and would not have received FDA approval
D says that "FDA regulates claims made about pharaceuticals more strictly than claims make about cosmetics"...but the passage suggets that the "standards" or experiments are more regerious for pharmaceuticals than cosmetics. I.e the Phramaceutical needs to meets higher standards than cosmetics. ..so its not the regulation of claims but the rigrousness of standards for pharmaceuticals......IMO
C ..can be infered because if DTF would have been approved for pharamaceutical then ..people will think that it meets higher standard and is more effective ...and will buy more